Trial Profile
Pilot Phase II, Randomized , and Control in Double Blind Placebo Effectiveness a 3 Months on Bleeding Fibroids Treatment With ULIPRISTAL ACETATE 10 mg/Day in Patients Suffering From Symptomatic Endometriosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2022
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Adenomyosis
- Focus Therapeutic Use
- Acronyms FRA-IIT-UPA
- 26 Sep 2022 Status changed from recruiting to completed.
- 11 Sep 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 11 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.